Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 6:2021:3825525.
doi: 10.1155/2021/3825525. eCollection 2021.

Relevance of Interleukins 6 and 8 Single Nucleotide Polymorphisms in Prostate Cancer: A Multicenter Study

Affiliations

Relevance of Interleukins 6 and 8 Single Nucleotide Polymorphisms in Prostate Cancer: A Multicenter Study

Amany A Ghazy et al. Prostate Cancer. .

Abstract

The diverse roles of cytokines as IL-6 and IL-8 have been studied in terms of their SNPs in many diseases but their role in prostate cancer (PCa) is still uncertain. Aim. To determine the relevance of IL-6 rs1800795 SNP and/or IL-8 rs2227306 SNP with prostate cancer's risk. Subjects and Methods. 40 PCa patients, 40 benign prostate hyperplasia (BPH) patients, and 40-age-matched-control group were enrolled in the study. Genotyping of IL-6 rs1800795 (G/C) SNP and IL-8 rs2227306 (C/T) SNP was determined using real-time PCR. Results. High frequency of IL-6 rs1800795GG and IL-8 rs2227306CC genotypes was noticed among PCa patients with associated OR 10.091 and 8.143, respectively. Comparisons based on allele frequencies revealed that IL-6G and IL-8C alleles are more frequent among PCa patients than other groups. Presence of IL-6 rs1800795G and IL-8 rs2227306C alleles in the same patient increase PCa risk by 16.7 times. Statistical correlations between PSA ratio and both of IL-6 and IL-8 SNP did not show any significant relation among PCa patients. Conclusion. IL-6 rs1800795G and IL-8 rs2227306C alleles could be considered risk factors for PCa development, particularly if presented together. However, no relation was found between both cytokines SNP and severity of prostate cancer.

PubMed Disclaimer

Conflict of interest statement

None of the contributing authors has any conflicts of interest.

Similar articles

Cited by

References

    1. Zambra F. M. B., Biolchi V., Brum I. S., Chies J. A. B. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer. Human Immunology. 2013;74(8):1003–1008. doi: 10.1016/j.humimm.2013.04.031. - DOI - PubMed
    1. Alenzi M. J., Ghazy A. A., Taha D. E. The weight of HLA-DPA1 rs3077 single nucleotide polymorphism in prostate cancer, a multicenter study. Prostate Cancer. 2021;2021:5. doi: 10.1155/2021/5539851.5539851 - DOI - PMC - PubMed
    1. Pang Y., Li H., Gong Y., et al. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia. Oncology Reports. 2019;41 doi: 10.3892/or.2019.7002. - DOI - PubMed
    1. Taheri M., Noroozi R., Dehghan A., Roozbahani G. A., Omrani M. D., Ghafouri-Fard S. Interleukin (IL)-8 polymorphisms and risk of prostate disorders. Gene. 2019;692:22–25. doi: 10.1016/j.gene.2019.01.005. - DOI - PubMed
    1. Guo Y., Zang Y., Lv L., et al. IL-8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF-κB pathway in prostate cancer. Molecular Medicine Report. 2017;16:9035–9042. doi: 10.3892/mmr.2017.7747. - DOI - PubMed